trientine has been researched along with deferiprone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chan, YK; Chen, X; Choong, SY; Cooper, GJ; Fitzpatrick, S; Glyn-Jones, S; Gong, D; Lu, J; Nakamura, T; Obolonkin, V; Phillips, AR; Poppitt, SD; Ruggiero, K; Xu, H; Zhang, S | 1 |
| Aaseth, J; Andersen, O; Cao, Y; Skaug, MA | 1 |
1 review(s) available for trientine and deferiprone
| Article | Year |
|---|---|
Chelation in metal intoxication--Principles and paradigms.
Topics: Administration, Oral; Antidotes; Benzoates; Chelating Agents; Deferasirox; Deferiprone; Deferoxamine; Heavy Metal Poisoning; Humans; Penicillamine; Poisoning; Pyridones; Succimer; Triazoles; Trientine; Unithiol | 2015 |
1 other study(ies) available for trientine and deferiprone
| Article | Year |
|---|---|
Copper(II)-selective chelation improves function and antioxidant defences in cardiovascular tissues of rats as a model of diabetes: comparisons between triethylenetetramine and three less copper-selective transition-metal-targeted treatments.
Topics: Adult; Aged; Analysis of Variance; Animals; Aorta; Chelating Agents; Deferiprone; Diabetes Mellitus, Experimental; Heart; Heparitin Sulfate; Humans; Kidney; Male; Middle Aged; Oxidative Stress; Penicillamine; Pyridones; Rats; Rats, Wistar; Trientine; Zinc Acetate | 2010 |